APA
Martínez-López I., Maurino J., Sanmartín-Fenollera P., Ontañon-Nasarre A., Santiago-Pérez A., Moya-Carmona I., García-Collado C. G., Fernández-Del Olmo R., García-Arcelay E., Sarmiento M., Carreño Á. & Pérez-Encinas M. (2020). Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. : Pharmacy (Basel, Switzerland).
Chicago
Martínez-López Iciar, Maurino Jorge, Sanmartín-Fenollera Patricia, Ontañon-Nasarre Ana, Santiago-Pérez Alejandro, Moya-Carmona Isabel, García-Collado Carlos Gustavo, Fernández-Del Olmo Raquel, García-Arcelay Elena, Sarmiento Mònica, Carreño Ágata and Pérez-Encinas Montserrat. 2020. Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. : Pharmacy (Basel, Switzerland).
Harvard
Martínez-López I., Maurino J., Sanmartín-Fenollera P., Ontañon-Nasarre A., Santiago-Pérez A., Moya-Carmona I., García-Collado C. G., Fernández-Del Olmo R., García-Arcelay E., Sarmiento M., Carreño Á. and Pérez-Encinas M. (2020). Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. : Pharmacy (Basel, Switzerland).
MLA
Martínez-López Iciar, Maurino Jorge, Sanmartín-Fenollera Patricia, Ontañon-Nasarre Ana, Santiago-Pérez Alejandro, Moya-Carmona Isabel, García-Collado Carlos Gustavo, Fernández-Del Olmo Raquel, García-Arcelay Elena, Sarmiento Mònica, Carreño Ágata and Pérez-Encinas Montserrat. Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. : Pharmacy (Basel, Switzerland). 2020.